A phase II study testing the safety and activity of AGS-003 as an immunotherapeutic in subjects with newly diagnosed advanced stage renal cell carcinoma (RCC) in combination with sunitinib.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. Amin, A. Dudek, T. Logan, R. S. Lance, J. M. Holzbeierlein, W. L. Williams, R. Jain, T. G. Chew, C. A. Nicolette, R. A. Figlin, AGS-003-006 Study Group
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2341705230